Compugen (CGEN) Stock Chart & Stock Price History $1.64 -0.07 (-4.09%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Compugen Stock Price Performance5 Day Performance+2.50%1 Month Performance-10.38%3 Month Performance0.00%6 Month Performance-22.27%Year-To-Date Performance-17.17%1 Year Performance+120.96% Receive CGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. CGEN Stock Chart for Tuesday, November, 5, 2024 CGEN Chart by TradingView Compugen Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$1.71$1.64-4.09%$1.68$1.63152,845 shs$146.35 million11/01/2024$1.60$1.71+6.87%$1.71$1.60172,143 shs$152.60 million10/31/2024$1.64$1.60-2.44%$1.64$1.59178,713 shs$142.78 million10/30/2024$1.67$1.64-1.80%$1.67$1.62126,947 shs$146.35 million10/29/2024$1.69$1.67-1.18%$1.68$1.6563,089 shs$149.03 million10/28/2024$1.70$1.69-0.59%$1.78$1.68267,513 shs$150.82 million Get the Latest News and Ratings for CGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$1.72$1.70-1.16%$1.75$1.67242,704 shs$151.71 million10/24/2024$1.69$1.72+1.78%$1.73$1.6690,850 shs$153.49 million10/23/2024$1.68$1.69+0.60%$1.71$1.63263,942 shs$150.82 million10/22/2024$1.71$1.68-1.75%$1.71$1.6684,387 shs$149.92 million10/21/2024$1.71$1.71$1.73$1.69164,625 shs$152.60 million10/18/2024$1.73$1.71-1.16%$1.73$1.7091,662 shs$152.60 million10/17/2024$1.70$1.73+1.76%$1.75$1.67210,339 shs$154.39 million10/16/2024$1.63$1.70+4.29%$1.70$1.61187,878 shs$151.71 million10/15/2024$1.68$1.63-2.98%$1.72$1.62325,519 shs$145.46 million10/14/2024$1.72$1.68-2.33%$1.74$1.66262,432 shs$149.92 million10/11/2024$1.72$1.72$1.77$1.70140,026 shs$153.49 million10/10/2024$1.74$1.72-1.15%$1.75$1.67270,798 shs$153.49 million10/09/2024$1.73$1.74+0.58%$1.75$1.7281,766 shs$155.28 million10/08/2024$1.77$1.73-2.26%$1.79$1.73135,168 shs$154.39 million10/07/2024$1.83$1.77-3.28%$1.81$1.75164,331 shs$157.96 million10/04/2024$1.78$1.83+2.81%$1.84$1.7895,282 shs$163.31 million10/03/2024$1.93$1.78-7.77%$1.98$1.77365,193 shs$158.85 million10/02/2024$1.85$1.93+4.32%$1.97$1.82510,445 shs$172.23 million10/01/2024$1.81$1.85+2.21%$1.86$1.75285,449 shs$165.09 million09/30/2024$1.81$1.81+0.28%$1.87$1.78100,488 shs$161.52 million09/27/2024$1.75$1.81+3.14%$1.88$1.78319,627 shs$161.08 million09/26/2024$1.74$1.75+0.57%$1.76$1.72100,310 shs$156.17 million09/25/2024$1.76$1.74-1.14%$1.79$1.73136,940 shs$155.28 million09/24/2024$1.76$1.76$1.79$1.75120,834 shs$157.06 million09/23/2024$1.83$1.76-3.83%$1.85$1.75262,964 shs$157.06 million09/20/2024$1.84$1.83-0.54%$1.88$1.82128,769 shs$163.31 million09/19/2024$1.90$1.84-3.16%$1.94$1.81206,387 shs$164.20 million09/18/2024$1.86$1.90+2.15%$1.97$1.88179,055 shs$169.56 million09/17/2024$1.92$1.86-3.12%$1.93$1.85133,068 shs$165.99 million09/16/2024$1.97$1.92-2.54%$1.97$1.90155,715 shs$171.34 million09/13/2024$1.96$1.97+0.51%$2.00$1.9290,467 shs$175.80 million09/12/2024$1.97$1.96-0.51%$2.01$1.95139,886 shs$174.91 million09/11/2024$1.94$1.97+1.55%$2.01$1.92178,079 shs$175.80 million09/10/2024$1.98$1.94-2.02%$2.00$1.93258,749 shs$173.13 millionWar on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.09/09/2024$1.83$1.98+8.20%$2.01$1.81357,336 shs$176.70 million09/06/2024$1.82$1.83+0.55%$1.89$1.80171,396 shs$163.31 million09/05/2024$1.97$1.82-7.61%$1.96$1.82548,953 shs$162.42 million09/04/2024$1.92$1.97+2.60%$1.99$1.90156,769 shs$175.80 million09/03/2024$2.10$1.92-8.57%$2.08$1.85537,748 shs$171.34 million09/02/2024$2.10$2.10$2.10$2.03166,300 shs$187.40 million08/30/2024$2.03$2.10+3.45%$2.10$2.03165,301 shs$181.92 million08/29/2024$1.90$2.03+6.84%$2.06$1.92202,197 shs$175.86 million08/28/2024$2.01$1.90-5.47%$2.00$1.90118,982 shs$164.60 million08/27/2024$2.05$2.01-1.95%$2.04$1.95178,840 shs$174.13 million08/26/2024$2.04$2.05+0.49%$2.07$1.92333,760 shs$177.59 million08/23/2024$2.04$2.04$2.13$1.99369,224 shs$176.73 million08/22/2024$1.97$2.04+3.55%$2.11$1.92490,692 shs$176.73 million08/21/2024$1.88$1.97+4.79%$2.00$1.88347,035 shs$170.66 million08/20/2024$1.79$1.88+5.03%$1.89$1.78222,513 shs$162.86 million08/19/2024$1.84$1.79-2.72%$1.84$1.77368,591 shs$155.07 million08/16/2024$1.81$1.84+1.66%$1.85$1.75173,575 shs$159.40 million08/15/2024$1.75$1.81+3.43%$1.83$1.73229,817 shs$156.80 million08/14/2024$1.75$1.75$1.77$1.71134,277 shs$151.60 million08/13/2024$1.67$1.75+4.79%$1.79$1.67242,335 shs$151.60 million08/12/2024$1.75$1.67-4.57%$1.74$1.63252,820 shs$144.67 million08/09/2024$1.75$1.75$1.77$1.72229,776 shs$151.60 million08/08/2024$1.63$1.75+7.36%$1.76$1.63195,659 shs$151.60 million08/07/2024$1.72$1.63-5.23%$1.74$1.62134,670 shs$141.21 million08/06/2024$1.64$1.72+4.88%$1.77$1.63208,117 shs$149.00 million08/05/2024$1.75$1.64-6.29%$1.67$1.57227,097 shs$142.07 million Related Companies Black Diamond Therapeutics Stock Price Chart Coherus BioSciences Stock Price Chart Inhibrx Stock Price Chart iTeos Therapeutics Stock Price Chart ORIC Pharmaceuticals Stock Price Chart Mereo BioPharma Group Stock Price Chart Nuvation Bio Stock Price Chart Korro Bio Stock Price Chart Neurogene Stock Price Chart Q32 Bio Stock Price Chart Receive CGEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGEN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
